Cancer stem cell targeting: are we there yet?

Area of Science:

• Oncology
• Cancer Biology
• Cellular Biology

Background:

• Cancer cell heterogeneity has long been recognized.
• The concept of cancer stem cells (CSCs) explains tumor initiation and heterogeneity.
• CSCs are implicated in therapeutic resistance and tumor recurrence.

Purpose of the Study:

• To review the historical context of CSC identification.
• To elucidate the role of CSCs in treatment resistance.
• To summarize current and emerging clinical strategies targeting CSCs.

Main Methods:

• Literature review of historical research on cancer heterogeneity and CSCs.
• Analysis of studies investigating CSCs' role in therapeutic resistance.
• Compilation and summary of ongoing clinical trials targeting CSCs.

Main Results:

• The existence of cancer stem cells is now widely accepted.
• CSCs contribute significantly to tumor resistance against conventional therapies.
• Various clinical trials are exploring targeted therapies against CSCs.

Conclusions:

• Targeting cancer stem cells is a promising strategy for improving cancer treatment outcomes.
• Understanding CSC biology is crucial for overcoming therapeutic resistance.
• Ongoing clinical trials represent the forefront of CSC-targeted cancer therapy development.